Vascular endothelial growth factor as prognostic factor in renal cell carcinoma

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 343-347

  Jacobsen, Jan ^a   Rasmuson, Torgny ^a   Grankvist, Kjell ^a   Ljungberg, Börje ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Prognosis; Renal cell carcinoma; Stage; VEGF; Vein invasion

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR VASCULARIZATION;

EID: 0033992036     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68049-4     Document Type: Article

References (25)

1. Weidner, N., Semple, J. P., Welch, W. R. and Folkman, J.: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med, 324: 1, 1991.
2. Senger, D. R., Van De Walter, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M. and Dvorak, H. F.: Vascular permeability factor (VPF, VEGF) in tumour biology. Cancer Metastasis Rev, 12: 303, 1993.
3. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D. W.: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. MoI Endocrinol, 5: 1806, 1991.
4. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J. and Leung, D. W.: The vascular endothelial growth factor family of polypeptides, J Cell Biochem, 47: 211, 1991.
5. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dworak, H. F. and Senger D. R.: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol, 143: 1255, 1993.
6. Sato, K., Terada, K., Sugiyama, T., Takahashi, S., Saito, M., Moriyama, M., Kakinuma, H., Suzuki, Y., Kato, M. and Kato, T.: Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma. Tohoku J Exp Med, 173: 355, 1994.
7. Nicol, D., Hii, S. I., Walsh, M., The, B., Thompson, L., Kennett, C. and Gotley, D.: Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol, 157: 1482, 1997.
8. Blath, R. A.; Mancilla-Jimenez, R and Stanley, R. J.: Clinical comparison between vascular and avascular renal cell carcinoma J Urol, 115: 514, 1976.
9. Ljungberg, B., Stenling, R., Österdahl, B., Farrelly, E., Åberg, T. and Roos, G.: Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol, 154: 1681, 1995.
10. McNichols, D. W., Segura, J. W. and DeWeerd, J. H.: Renal cell carcinoma: long-term survival and late recurrence. J Urol, 126: 17, 1981.
11. Hatcher, P. A., Anderson, E. E., Poulson, D. F., Carson, C. C. and Robertson, J. E.: Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol, 145: 20, 1991.
12. Golimbo, M., Joshi, P., Sperber, A., Tessler, A., AL-Askari, S. and Morales, P.: Renal cell carcinoma: survival and prognostic factors. Urology, 27: 291, 1986.
13. Sobin, L. H. and Wittekind, Ch.: International Union Against Cancer (UICC), TNM Classification of Malignant Tumors. Wiley-Liss: New York, pp. 180-182, 1997.
14. Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C. and Leadbetter, W. F.: Diagnosis and management of renal cell carcinoma. Cancer, 28: 1165, 1971.
15. Kovacs, G., Akhtar, M., Beckwith, B. J., Bugert, P., Cooper, C. S., Delahunt, B., Eble, J. N., Fleming, S., Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel, S., Vandenberg, E. and Zbar, B.: The Heidelberg classification of renal cell tumors. J Pathol, 183: 131, 1997.
16. Folkman, J.: The role of angiogenesis in tumor growth. Semin Cancer Biol, 3: 65, 1992.
17. Stein, I., Neeman, M., Shweiki, D., Itin, A. and Keshet, E.: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol, 15: 5363, 1995.
18. Simon, M., Rockl, W., Hornig, C., Grone, E. F., Theis, H., Weich, H. A., Fuchs, E., Yayon, A. and Grone, H. J.: Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localisation and [125I] VEGF binding sites. J Am Soc Nephrol, 9: 1032, 1998.
19. Web, N. J., Bottomley, M. J., Watson, C. J. and Brenchley, P. E.: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci, 94: 395, 1998.
20. Heer, K., Kumar, H., Speirs, V., Greenman, J., Drew, P. J., Fox, J. N., Charleston, P. J., Monson, J. R. T. and Kerin, M. J.: Vascular endothelial growth factor in premenopausal women -indicator of the best time for breast cancer surgery? Br J Cancer, 78: 1203, 1998.
21. Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C, and Selby, P. J.: Release of the angiogenic cytokine vascular endotholial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer, 77: 956, 1998.
22. Linderholm, B., Tavelin, B., Grankvist, K. and Henriksson, R. J.: Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol, 16: 3121, 1998.
23. Baccala, A. A., Zhong, H., Clift, S. M., Nelson, W. G., Marshall, F. F., Passe, T. J., Gambill, N. B. and Simons, J. W.: Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumour response to ex vivo gene therapy of renal cell cancer. Urology, 51: 327, 1998.
24. Salven, P., Ruotsalainen, T., Mattson, K, and Joensuu, H.: High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer, 79: 144, 1998.
25. Mattern, J., Stammler, G., Koomagi, R., Wallwiener, D., Kaufmann, M. and Volm, M.: Association of vascular endothelial growth factor expression with tumour cell proliferation in ovarian carcinoma. Anticancer Res, 17: 621, 1997.